Institute of Applied Biotechnologies (Czechia)
This is a multidisciplinary, highly innovative project focused on the development of HemaSeqDX diagnostic kits and panels for the detection of clinically relevantmutations in chronic lymphocytic leukemia and multiple myeloma,... Join virtually for four dynamic days to experience a new era of optical genome mapping (OGM), featuring 30+ global experts sharing pioneering data and real-world applications across hematologic malignancies, solid... The aim of the ENIGMA project is to develop a Czech di
Basic Information
- Category: business
- Website: http://www.iabio.cz/
Documented Facts
- Email: iabio@iabio.eu (No linked source recorded for this statement.)
Evidence and Sources
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Institute of Applied Biotechnologies (Czechia).
- Canonical profile: https://brandsource.ai/brands/institute-of-applied-biotechnologies-czechia
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/institute-of-applied-biotechnologies-czechia/json-ld
- Citation profile API: https://brandsource.ai/api/brands/institute-of-applied-biotechnologies-czechia/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (77/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
This is a multidisciplinary, highly innovative project focused on the development of HemaSeqDX diagnostic kits and panels for the detection of clinically relevantmutations in chronic lymphocytic leukemia and multiple myeloma,... Join virtually for four dynamic days to experience a new era of optical genome mapping (OGM), featuring 30+ global experts sharing pioneering data and real-world applications across hematologic malignancies, solid... The aim of the ENIGMA project is to develop a Czech di
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.